BioStem Life Sciences maintains banks of perinatal tissue derived MSCs, also called Mesenchymal Stem Cells, produced under cGMP conditions for expansion and use in human clinical trials as well as in research applications that are anticipated to lead to clinical development. Perinatal tissue donations were collected with full informed consent and 21 CFR 1271 Donor Eligibility Testing. The donations were processed under cGMPs. Options also exist for custom donor acquisition through a collaborator's IRB and Master Cell Bank production.
Have Questions? Reach out to us
If you have questions about the company, our lab, our scientific team or anything else, please feel free to contact us.